Dimethyl Fumarate Capsule, Delayed Release
Product Images NDC 69097-323

Product Visual Gallery

This gallery contains 9 technical images submitted to the FDA as part of the official labeling for Dimethyl Fumarate (NDC 69097-323). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Cipla Usa Inc., these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Image (036d5aa7 Ae73 450a B6dc B129b4448cc8 01)

Chemical structure of Dimethyl Fumarate, showing its molecular configuration with two ester groups and a double bond in the fumarate backbone.*

FDA Label Image

Image (036d5aa7 Ae73 450a B6dc B129b4448cc8 02)

A line graph comparing the percentage of subjects with confirmed progression of disability over time in weeks up to 96 weeks between placebo and Dimethyl Fumarate 240 mg BID groups. The vertical axis shows the percentage, and the horizontal axis represents time on study. The graph indicates 27.1% progression in the placebo group and 16.4% in the Dimethyl Fumarate group at 96 weeks.*

FDA Label Image

1 (036d5aa7 Ae73 450a B6dc B129b4448cc8 03)

Label for Dimethyl Fumarate delayed-release capsules, 120 mg strength, identified as a starter dose with instructions to take one capsule twice a day on days 1 to 7. The label notes 14 capsules per package and indicates it is manufactured by MSN Laboratories Private Limited and labeled for Cipla USA Inc. It includes storage instructions and barcode data.*

FDA Label Image

Principal Display Panel -cipla-starter-pack-label-240mg-46s (036d5aa7 Ae73 450a B6dc B129b4448cc8 04)

Label for Dimethyl Fumarate delayed-release capsules, 240 mg strength, by Cipla USA Inc. The label states to take one capsule twice a day on days 8 to 30, swallowing capsules whole. It includes storage instructions and manufacturer details for MSN Laboratories Private Limited, India, and Cipla USA, Inc., New Jersey. The label also displays a barcode, NDC 69097-323-88, and placeholders for lot and expiration date coding.*

FDA Label Image

Principal Display Panel-cipla-label-120mg-14s (036d5aa7 Ae73 450a B6dc B129b4448cc8 05)

Label for Dimethyl Fumarate 120 mg delayed-release capsules, oral use. The label states a quantity of 14 capsules per container. It is manufactured by MSN Laboratories Pvt. Ltd., India, for Cipla USA Inc. The label includes storage instructions and a barcode, with the Cipla logo at the bottom.*

FDA Label Image

Principal Display Panel-cipla-label-240mg-60s (036d5aa7 Ae73 450a B6dc B129b4448cc8 06)

Dimethyl Fumarate delayed-release capsules 240 mg label shows a white and blue label for a 60-capsule bottle. The label includes the active ingredient strength (240 mg), dosage form, swallowing instructions, manufacturer details (MSN Laboratories Private Limited, India), and that it is manufactured for Cipla USA Inc., located in Warren, NJ. Storage and dosage instructions are also included, along with NDC code and barcode.*

FDA Label Image

Carton-label (036d5aa7 Ae73 450a B6dc B129b4448cc8 07)

Packaging label for Dimethyl Fumarate delayed-release capsules, 120 mg strength. The label shows the product name prominently with dosage form and strength, instructions to swallow the capsule whole, and contains 14 capsules per package. Manufactured by MSN Laboratories Private Limited for Cipla USA Inc. The label includes NDC 69097-322-89 and barcodes on multiple panels with additional handling instructions and storage temperatures.*

FDA Label Image

6 (036d5aa7 Ae73 450a B6dc B129b4448cc8 08)

Packaging label for Dimethyl Fumarate delayed-release capsules, 240 mg, with a count of 60 capsules per container. The label includes the NDC 69097-323-03 and indicates Rx only. The product is manufactured by MSN Laboratories Private Limited and labeled by Cipla USA Inc. The label contains dosage and storage instructions, barcode, and contact information for support.*

FDA Label Image

Starter Pack (036d5aa7 Ae73 450a B6dc B129b4448cc8 09)

Packaging label for Dimethyl Fumarate delayed-release capsules 30-Day Starter Pack by Cipla USA Inc. It includes two dosage strengths: 120 mg Starter Dose with 14 capsules and 240 mg Regular Dose with 46 capsules. The label details package contents, manufacturer information, dosage instructions, storage conditions, and features the Cipla logo and barcode.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.